nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—Dyspnoea—Levobunolol—glaucoma	0.00271	0.00438	CcSEcCtD
Carfilzomib—Constipation—Diclofenamide—glaucoma	0.00271	0.00437	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Pilocarpine—glaucoma	0.0027	0.00436	CcSEcCtD
Carfilzomib—Pain—Carbachol—glaucoma	0.00264	0.00427	CcSEcCtD
Carfilzomib—Pain—Levobunolol—glaucoma	0.0026	0.0042	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Latanoprost—glaucoma	0.00257	0.00415	CcSEcCtD
Carfilzomib—Hypoaesthesia—Brinzolamide—glaucoma	0.00255	0.00411	CcSEcCtD
Carfilzomib—Decreased appetite—Methazolamide—glaucoma	0.00254	0.00409	CcSEcCtD
Carfilzomib—Cardiac disorder—Brimonidine—glaucoma	0.00253	0.00408	CcSEcCtD
Carfilzomib—Oedema peripheral—Brinzolamide—glaucoma	0.00252	0.00407	CcSEcCtD
Carfilzomib—Dyspnoea—Latanoprost—glaucoma	0.00252	0.00406	CcSEcCtD
Carfilzomib—Fatigue—Methazolamide—glaucoma	0.00251	0.00406	CcSEcCtD
Carfilzomib—Body temperature increased—Diclofenamide—glaucoma	0.0025	0.00404	CcSEcCtD
Carfilzomib—Asthenia—Metipranolol—glaucoma	0.00249	0.00403	CcSEcCtD
Carfilzomib—Hypoaesthesia—Pilocarpine—glaucoma	0.00245	0.00395	CcSEcCtD
Carfilzomib—Body temperature increased—Carbachol—glaucoma	0.00244	0.00394	CcSEcCtD
Carfilzomib—Oedema peripheral—Pilocarpine—glaucoma	0.00242	0.00391	CcSEcCtD
Carfilzomib—Pain—Latanoprost—glaucoma	0.00241	0.0039	CcSEcCtD
Carfilzomib—Cardiac disorder—Travoprost—glaucoma	0.00241	0.00388	CcSEcCtD
Carfilzomib—Cardiac disorder—Brinzolamide—glaucoma	0.00238	0.00383	CcSEcCtD
Carfilzomib—Cough—Bimatoprost—glaucoma	0.00234	0.00378	CcSEcCtD
Carfilzomib—Hypertension—Bimatoprost—glaucoma	0.00231	0.00374	CcSEcCtD
Carfilzomib—Asthenia—Carteolol—glaucoma	0.00231	0.00373	CcSEcCtD
Carfilzomib—Body temperature increased—Methazolamide—glaucoma	0.00231	0.00372	CcSEcCtD
Carfilzomib—Dizziness—Metipranolol—glaucoma	0.0023	0.00371	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Clonidine—glaucoma	0.00228	0.00368	CcSEcCtD
Carfilzomib—Asthenia—Diclofenamide—glaucoma	0.00227	0.00367	CcSEcCtD
Carfilzomib—Hypokalaemia—Betaxolol—glaucoma	0.00225	0.00363	CcSEcCtD
Carfilzomib—Infection—Apraclonidine—glaucoma	0.00224	0.00362	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Timolol—glaucoma	0.00223	0.0036	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.00223	0.00359	CcSEcCtD
Carfilzomib—Leukopenia—Acetazolamide—glaucoma	0.00221	0.00357	CcSEcCtD
Carfilzomib—Chills—Pilocarpine—glaucoma	0.00221	0.00356	CcSEcCtD
Carfilzomib—Back pain—Dorzolamide—glaucoma	0.00219	0.00354	CcSEcCtD
Carfilzomib—Asthenia—Levobunolol—glaucoma	0.00218	0.00352	CcSEcCtD
Carfilzomib—Back pain—Travoprost—glaucoma	0.00218	0.00352	CcSEcCtD
Carfilzomib—Headache—Metipranolol—glaucoma	0.00218	0.00352	CcSEcCtD
Carfilzomib—Infection—Bimatoprost—glaucoma	0.00217	0.00351	CcSEcCtD
Carfilzomib—Back pain—Brinzolamide—glaucoma	0.00216	0.00348	CcSEcCtD
Carfilzomib—Muscle spasms—Brinzolamide—glaucoma	0.00214	0.00346	CcSEcCtD
Carfilzomib—Dizziness—Carteolol—glaucoma	0.00213	0.00344	CcSEcCtD
Carfilzomib—Diarrhoea—Carbachol—glaucoma	0.00212	0.00341	CcSEcCtD
Carfilzomib—Dizziness—Diclofenamide—glaucoma	0.00209	0.00338	CcSEcCtD
Carfilzomib—Asthenia—Methazolamide—glaucoma	0.00209	0.00338	CcSEcCtD
Carfilzomib—Diarrhoea—Levobunolol—glaucoma	0.00208	0.00336	CcSEcCtD
Carfilzomib—Back pain—Pilocarpine—glaucoma	0.00207	0.00334	CcSEcCtD
Carfilzomib—Cough—Brimonidine—glaucoma	0.00207	0.00334	CcSEcCtD
Carfilzomib—Nausea—Metipranolol—glaucoma	0.00207	0.00333	CcSEcCtD
Carfilzomib—Muscle spasms—Pilocarpine—glaucoma	0.00206	0.00332	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.00206	0.00332	CcSEcCtD
Carfilzomib—Hypertension—Brimonidine—glaucoma	0.00205	0.00331	CcSEcCtD
Carfilzomib—Dizziness—Carbachol—glaucoma	0.00204	0.0033	CcSEcCtD
Carfilzomib—Insomnia—Apraclonidine—glaucoma	0.00204	0.00329	CcSEcCtD
Carfilzomib—Arthralgia—Brimonidine—glaucoma	0.00202	0.00326	CcSEcCtD
Carfilzomib—Pain in extremity—Timolol—glaucoma	0.00202	0.00326	CcSEcCtD
Carfilzomib—Headache—Carteolol—glaucoma	0.00202	0.00326	CcSEcCtD
Carfilzomib—Vomiting—Diclofenamide—glaucoma	0.00201	0.00325	CcSEcCtD
Carfilzomib—Dizziness—Levobunolol—glaucoma	0.00201	0.00325	CcSEcCtD
Carfilzomib—Dyspnoea—Apraclonidine—glaucoma	0.00201	0.00325	CcSEcCtD
Carfilzomib—Diarrhoea—Methazolamide—glaucoma	0.002	0.00322	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Betaxolol—glaucoma	0.00199	0.00321	CcSEcCtD
Carfilzomib—Headache—Diclofenamide—glaucoma	0.00198	0.0032	CcSEcCtD
Carfilzomib—Insomnia—Bimatoprost—glaucoma	0.00198	0.00319	CcSEcCtD
Carfilzomib—Cough—Dorzolamide—glaucoma	0.00198	0.00319	CcSEcCtD
Carfilzomib—Thrombocytopenia—Acetazolamide—glaucoma	0.00198	0.00319	CcSEcCtD
Carfilzomib—Cough—Travoprost—glaucoma	0.00197	0.00318	CcSEcCtD
Carfilzomib—Vomiting—Carbachol—glaucoma	0.00197	0.00317	CcSEcCtD
Carfilzomib—Hypertension—Dorzolamide—glaucoma	0.00196	0.00316	CcSEcCtD
Carfilzomib—Hypoaesthesia—Clonidine—glaucoma	0.00196	0.00316	CcSEcCtD
Carfilzomib—Dyspnoea—Bimatoprost—glaucoma	0.00195	0.00315	CcSEcCtD
Carfilzomib—Hypertension—Travoprost—glaucoma	0.00195	0.00315	CcSEcCtD
Carfilzomib—Fatigue—Apraclonidine—glaucoma	0.00195	0.00314	CcSEcCtD
Carfilzomib—Cough—Brinzolamide—glaucoma	0.00194	0.00314	CcSEcCtD
Carfilzomib—Headache—Carbachol—glaucoma	0.00194	0.00313	CcSEcCtD
Carfilzomib—Arthralgia—Dorzolamide—glaucoma	0.00193	0.00311	CcSEcCtD
Carfilzomib—Constipation—Apraclonidine—glaucoma	0.00193	0.00311	CcSEcCtD
Carfilzomib—Pain—Apraclonidine—glaucoma	0.00193	0.00311	CcSEcCtD
Carfilzomib—Hyperglycaemia—Betaxolol—glaucoma	0.00193	0.00311	CcSEcCtD
Carfilzomib—Infection—Brimonidine—glaucoma	0.00192	0.00311	CcSEcCtD
Carfilzomib—Hypertension—Brinzolamide—glaucoma	0.00192	0.00311	CcSEcCtD
Carfilzomib—Arthralgia—Travoprost—glaucoma	0.00192	0.0031	CcSEcCtD
Carfilzomib—Cardiac arrest—Timolol—glaucoma	0.00192	0.0031	CcSEcCtD
Carfilzomib—Leukopenia—Pilocarpine—glaucoma	0.00192	0.00309	CcSEcCtD
Carfilzomib—Pneumonia—Betaxolol—glaucoma	0.00192	0.00309	CcSEcCtD
Carfilzomib—Nausea—Carteolol—glaucoma	0.00191	0.00309	CcSEcCtD
Carfilzomib—Headache—Levobunolol—glaucoma	0.00191	0.00308	CcSEcCtD
Carfilzomib—Arthralgia—Brinzolamide—glaucoma	0.0019	0.00306	CcSEcCtD
Carfilzomib—Nausea—Diclofenamide—glaucoma	0.00188	0.00304	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Betaxolol—glaucoma	0.00188	0.00303	CcSEcCtD
Carfilzomib—Pain—Bimatoprost—glaucoma	0.00187	0.00302	CcSEcCtD
Carfilzomib—Cough—Pilocarpine—glaucoma	0.00187	0.00302	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Betaxolol—glaucoma	0.00187	0.00301	CcSEcCtD
Carfilzomib—Dizziness—Latanoprost—glaucoma	0.00187	0.00301	CcSEcCtD
Carfilzomib—Vomiting—Methazolamide—glaucoma	0.00185	0.00299	CcSEcCtD
Carfilzomib—Hypertension—Pilocarpine—glaucoma	0.00185	0.00298	CcSEcCtD
Carfilzomib—Nausea—Carbachol—glaucoma	0.00184	0.00296	CcSEcCtD
Carfilzomib—Infection—Travoprost—glaucoma	0.00183	0.00295	CcSEcCtD
Carfilzomib—Headache—Methazolamide—glaucoma	0.00183	0.00295	CcSEcCtD
Carfilzomib—Cardiac disorder—Clonidine—glaucoma	0.00182	0.00294	CcSEcCtD
Carfilzomib—Arthralgia—Pilocarpine—glaucoma	0.00182	0.00294	CcSEcCtD
Carfilzomib—Nausea—Levobunolol—glaucoma	0.00181	0.00292	CcSEcCtD
Carfilzomib—Infection—Brinzolamide—glaucoma	0.00181	0.00292	CcSEcCtD
Carfilzomib—Headache—Latanoprost—glaucoma	0.00177	0.00285	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Brimonidine—glaucoma	0.00177	0.00285	CcSEcCtD
Carfilzomib—Anorexia—Dorzolamide—glaucoma	0.00176	0.00285	CcSEcCtD
Carfilzomib—Decreased appetite—Acetazolamide—glaucoma	0.00175	0.00283	CcSEcCtD
Carfilzomib—Insomnia—Brimonidine—glaucoma	0.00175	0.00283	CcSEcCtD
Carfilzomib—Fatigue—Acetazolamide—glaucoma	0.00174	0.00281	CcSEcCtD
Carfilzomib—Infection—Pilocarpine—glaucoma	0.00174	0.0028	CcSEcCtD
Carfilzomib—Nausea—Methazolamide—glaucoma	0.00173	0.0028	CcSEcCtD
Carfilzomib—Dyspnoea—Brimonidine—glaucoma	0.00173	0.00279	CcSEcCtD
Carfilzomib—Thrombocytopenia—Pilocarpine—glaucoma	0.00171	0.00276	CcSEcCtD
Carfilzomib—Hypoaesthesia—Betaxolol—glaucoma	0.0017	0.00275	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.00169	0.00272	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Travoprost—glaucoma	0.00168	0.00271	CcSEcCtD
Carfilzomib—Insomnia—Dorzolamide—glaucoma	0.00167	0.0027	CcSEcCtD
Carfilzomib—Fatigue—Brimonidine—glaucoma	0.00167	0.0027	CcSEcCtD
Carfilzomib—Anorexia—Pilocarpine—glaucoma	0.00167	0.00269	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.00166	0.00267	CcSEcCtD
Carfilzomib—Pain—Brimonidine—glaucoma	0.00166	0.00267	CcSEcCtD
Carfilzomib—Dyspnoea—Dorzolamide—glaucoma	0.00165	0.00266	CcSEcCtD
Carfilzomib—Insomnia—Brinzolamide—glaucoma	0.00165	0.00266	CcSEcCtD
Carfilzomib—Muscle spasms—Clonidine—glaucoma	0.00164	0.00265	CcSEcCtD
Carfilzomib—Dyspnoea—Travoprost—glaucoma	0.00164	0.00265	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Timolol—glaucoma	0.00162	0.00262	CcSEcCtD
Carfilzomib—Dyspnoea—Brinzolamide—glaucoma	0.00162	0.00262	CcSEcCtD
Carfilzomib—Asthenia—Apraclonidine—glaucoma	0.00162	0.00261	CcSEcCtD
Carfilzomib—Decreased appetite—Dorzolamide—glaucoma	0.00161	0.0026	CcSEcCtD
Carfilzomib—Body temperature increased—Acetazolamide—glaucoma	0.0016	0.00258	CcSEcCtD
Carfilzomib—Fatigue—Dorzolamide—glaucoma	0.0016	0.00257	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00159	0.00257	CcSEcCtD
Carfilzomib—Fatigue—Travoprost—glaucoma	0.00159	0.00256	CcSEcCtD
Carfilzomib—Cardiac disorder—Betaxolol—glaucoma	0.00159	0.00256	CcSEcCtD
Carfilzomib—Pain—Dorzolamide—glaucoma	0.00158	0.00255	CcSEcCtD
Carfilzomib—Insomnia—Pilocarpine—glaucoma	0.00158	0.00255	CcSEcCtD
Carfilzomib—Decreased appetite—Brinzolamide—glaucoma	0.00158	0.00255	CcSEcCtD
Carfilzomib—Constipation—Travoprost—glaucoma	0.00158	0.00254	CcSEcCtD
Carfilzomib—Pain—Travoprost—glaucoma	0.00158	0.00254	CcSEcCtD
Carfilzomib—Hyperglycaemia—Timolol—glaucoma	0.00158	0.00254	CcSEcCtD
Carfilzomib—Asthenia—Bimatoprost—glaucoma	0.00157	0.00253	CcSEcCtD
Carfilzomib—Fatigue—Brinzolamide—glaucoma	0.00157	0.00253	CcSEcCtD
Carfilzomib—Dyspnoea—Pilocarpine—glaucoma	0.00156	0.00252	CcSEcCtD
Carfilzomib—Pain—Brinzolamide—glaucoma	0.00156	0.00251	CcSEcCtD
Carfilzomib—Diarrhoea—Apraclonidine—glaucoma	0.00154	0.00249	CcSEcCtD
Carfilzomib—Chills—Betaxolol—glaucoma	0.00154	0.00248	CcSEcCtD
Carfilzomib—Decreased appetite—Pilocarpine—glaucoma	0.00152	0.00245	CcSEcCtD
Carfilzomib—Pain—Pilocarpine—glaucoma	0.0015	0.00241	CcSEcCtD
Carfilzomib—Constipation—Pilocarpine—glaucoma	0.0015	0.00241	CcSEcCtD
Carfilzomib—Cough—Clonidine—glaucoma	0.00149	0.00241	CcSEcCtD
Carfilzomib—Dizziness—Apraclonidine—glaucoma	0.00149	0.00241	CcSEcCtD
Carfilzomib—Body temperature increased—Dorzolamide—glaucoma	0.00146	0.00236	CcSEcCtD
Carfilzomib—Arthralgia—Clonidine—glaucoma	0.00146	0.00235	CcSEcCtD
Carfilzomib—Asthenia—Acetazolamide—glaucoma	0.00145	0.00234	CcSEcCtD
Carfilzomib—Dizziness—Bimatoprost—glaucoma	0.00145	0.00233	CcSEcCtD
Carfilzomib—Vomiting—Apraclonidine—glaucoma	0.00143	0.00232	CcSEcCtD
Carfilzomib—Muscle spasms—Betaxolol—glaucoma	0.00143	0.00231	CcSEcCtD
Carfilzomib—Headache—Apraclonidine—glaucoma	0.00141	0.00228	CcSEcCtD
Carfilzomib—Asthenia—Brimonidine—glaucoma	0.00139	0.00224	CcSEcCtD
Carfilzomib—Infection—Clonidine—glaucoma	0.00139	0.00224	CcSEcCtD
Carfilzomib—Body temperature increased—Pilocarpine—glaucoma	0.00138	0.00223	CcSEcCtD
Carfilzomib—Diarrhoea—Acetazolamide—glaucoma	0.00138	0.00223	CcSEcCtD
Carfilzomib—Oedema peripheral—Timolol—glaucoma	0.00138	0.00222	CcSEcCtD
Carfilzomib—Anaemia—Betaxolol—glaucoma	0.00138	0.00222	CcSEcCtD
Carfilzomib—Headache—Bimatoprost—glaucoma	0.00137	0.00221	CcSEcCtD
Carfilzomib—Thrombocytopenia—Clonidine—glaucoma	0.00137	0.00221	CcSEcCtD
Carfilzomib—Nausea—Apraclonidine—glaucoma	0.00134	0.00216	CcSEcCtD
Carfilzomib—Dizziness—Acetazolamide—glaucoma	0.00133	0.00215	CcSEcCtD
Carfilzomib—Anorexia—Clonidine—glaucoma	0.00133	0.00215	CcSEcCtD
Carfilzomib—Asthenia—Dorzolamide—glaucoma	0.00133	0.00214	CcSEcCtD
Carfilzomib—Asthenia—Travoprost—glaucoma	0.00132	0.00213	CcSEcCtD
Carfilzomib—Asthenia—Brinzolamide—glaucoma	0.00131	0.00211	CcSEcCtD
Carfilzomib—Cough—Betaxolol—glaucoma	0.0013	0.0021	CcSEcCtD
Carfilzomib—Nausea—Bimatoprost—glaucoma	0.0013	0.0021	CcSEcCtD
Carfilzomib—Cardiac disorder—Timolol—glaucoma	0.0013	0.00209	CcSEcCtD
Carfilzomib—Vomiting—Acetazolamide—glaucoma	0.00128	0.00207	CcSEcCtD
Carfilzomib—Dizziness—Brimonidine—glaucoma	0.00128	0.00207	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Clonidine—glaucoma	0.00127	0.00205	CcSEcCtD
Carfilzomib—Arthralgia—Betaxolol—glaucoma	0.00127	0.00205	CcSEcCtD
Carfilzomib—Diarrhoea—Dorzolamide—glaucoma	0.00127	0.00204	CcSEcCtD
Carfilzomib—Headache—Acetazolamide—glaucoma	0.00126	0.00204	CcSEcCtD
Carfilzomib—Insomnia—Clonidine—glaucoma	0.00126	0.00204	CcSEcCtD
Carfilzomib—Diarrhoea—Travoprost—glaucoma	0.00126	0.00203	CcSEcCtD
Carfilzomib—Asthenia—Pilocarpine—glaucoma	0.00125	0.00202	CcSEcCtD
Carfilzomib—Dyspnoea—Clonidine—glaucoma	0.00124	0.00201	CcSEcCtD
Carfilzomib—Diarrhoea—Brinzolamide—glaucoma	0.00124	0.00201	CcSEcCtD
Carfilzomib—Dizziness—Dorzolamide—glaucoma	0.00122	0.00197	CcSEcCtD
Carfilzomib—Dizziness—Travoprost—glaucoma	0.00122	0.00197	CcSEcCtD
Carfilzomib—Headache—Brimonidine—glaucoma	0.00121	0.00196	CcSEcCtD
Carfilzomib—Decreased appetite—Clonidine—glaucoma	0.00121	0.00196	CcSEcCtD
Carfilzomib—Infection—Betaxolol—glaucoma	0.00121	0.00195	CcSEcCtD
Carfilzomib—Fatigue—Clonidine—glaucoma	0.0012	0.00194	CcSEcCtD
Carfilzomib—Dizziness—Brinzolamide—glaucoma	0.0012	0.00194	CcSEcCtD
Carfilzomib—Nausea—Acetazolamide—glaucoma	0.0012	0.00193	CcSEcCtD
Carfilzomib—Diarrhoea—Pilocarpine—glaucoma	0.0012	0.00193	CcSEcCtD
Carfilzomib—Constipation—Clonidine—glaucoma	0.00119	0.00193	CcSEcCtD
Carfilzomib—Pain—Clonidine—glaucoma	0.00119	0.00193	CcSEcCtD
Carfilzomib—Thrombocytopenia—Betaxolol—glaucoma	0.00119	0.00192	CcSEcCtD
Carfilzomib—Vomiting—Dorzolamide—glaucoma	0.00118	0.0019	CcSEcCtD
Carfilzomib—Headache—Dorzolamide—glaucoma	0.00116	0.00187	CcSEcCtD
Carfilzomib—Anorexia—Betaxolol—glaucoma	0.00116	0.00187	CcSEcCtD
Carfilzomib—Vomiting—Brinzolamide—glaucoma	0.00116	0.00187	CcSEcCtD
Carfilzomib—Dizziness—Pilocarpine—glaucoma	0.00116	0.00187	CcSEcCtD
Carfilzomib—Headache—Travoprost—glaucoma	0.00115	0.00186	CcSEcCtD
Carfilzomib—Nausea—Brimonidine—glaucoma	0.00115	0.00186	CcSEcCtD
Carfilzomib—Headache—Brinzolamide—glaucoma	0.00114	0.00184	CcSEcCtD
Carfilzomib—Vomiting—Pilocarpine—glaucoma	0.00111	0.00179	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00111	0.00179	CcSEcCtD
Carfilzomib—Body temperature increased—Clonidine—glaucoma	0.0011	0.00178	CcSEcCtD
Carfilzomib—Insomnia—Betaxolol—glaucoma	0.0011	0.00177	CcSEcCtD
Carfilzomib—Nausea—Dorzolamide—glaucoma	0.0011	0.00177	CcSEcCtD
Carfilzomib—Headache—Pilocarpine—glaucoma	0.0011	0.00177	CcSEcCtD
Carfilzomib—Nausea—Travoprost—glaucoma	0.00109	0.00177	CcSEcCtD
Carfilzomib—Dyspnoea—Betaxolol—glaucoma	0.00108	0.00175	CcSEcCtD
Carfilzomib—Nausea—Brinzolamide—glaucoma	0.00108	0.00174	CcSEcCtD
Carfilzomib—Cough—Timolol—glaucoma	0.00106	0.00171	CcSEcCtD
Carfilzomib—Decreased appetite—Betaxolol—glaucoma	0.00106	0.00171	CcSEcCtD
Carfilzomib—Hypertension—Timolol—glaucoma	0.00105	0.0017	CcSEcCtD
Carfilzomib—Fatigue—Betaxolol—glaucoma	0.00105	0.00169	CcSEcCtD
Carfilzomib—Pain—Betaxolol—glaucoma	0.00104	0.00168	CcSEcCtD
Carfilzomib—Constipation—Betaxolol—glaucoma	0.00104	0.00168	CcSEcCtD
Carfilzomib—Nausea—Pilocarpine—glaucoma	0.00104	0.00168	CcSEcCtD
Carfilzomib—Arthralgia—Timolol—glaucoma	0.00104	0.00167	CcSEcCtD
Carfilzomib—Asthenia—Clonidine—glaucoma	0.001	0.00162	CcSEcCtD
Carfilzomib—Infection—Timolol—glaucoma	0.000987	0.00159	CcSEcCtD
Carfilzomib—Body temperature increased—Betaxolol—glaucoma	0.000961	0.00155	CcSEcCtD
Carfilzomib—Diarrhoea—Clonidine—glaucoma	0.000955	0.00154	CcSEcCtD
Carfilzomib—Anorexia—Timolol—glaucoma	0.000947	0.00153	CcSEcCtD
Carfilzomib—Dizziness—Clonidine—glaucoma	0.000923	0.00149	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Timolol—glaucoma	0.000905	0.00146	CcSEcCtD
Carfilzomib—Insomnia—Timolol—glaucoma	0.000898	0.00145	CcSEcCtD
Carfilzomib—Vomiting—Clonidine—glaucoma	0.000888	0.00143	CcSEcCtD
Carfilzomib—Dyspnoea—Timolol—glaucoma	0.000885	0.00143	CcSEcCtD
Carfilzomib—Headache—Clonidine—glaucoma	0.000875	0.00141	CcSEcCtD
Carfilzomib—Asthenia—Betaxolol—glaucoma	0.000872	0.00141	CcSEcCtD
Carfilzomib—Decreased appetite—Timolol—glaucoma	0.000863	0.00139	CcSEcCtD
Carfilzomib—Fatigue—Timolol—glaucoma	0.000856	0.00138	CcSEcCtD
Carfilzomib—Pain—Timolol—glaucoma	0.000849	0.00137	CcSEcCtD
Carfilzomib—Diarrhoea—Betaxolol—glaucoma	0.000832	0.00134	CcSEcCtD
Carfilzomib—Nausea—Clonidine—glaucoma	0.000829	0.00134	CcSEcCtD
Carfilzomib—Dizziness—Betaxolol—glaucoma	0.000804	0.0013	CcSEcCtD
Carfilzomib—Body temperature increased—Timolol—glaucoma	0.000785	0.00127	CcSEcCtD
Carfilzomib—Vomiting—Betaxolol—glaucoma	0.000773	0.00125	CcSEcCtD
Carfilzomib—Headache—Betaxolol—glaucoma	0.000761	0.00123	CcSEcCtD
Carfilzomib—Nausea—Betaxolol—glaucoma	0.000722	0.00117	CcSEcCtD
Carfilzomib—Asthenia—Timolol—glaucoma	0.000712	0.00115	CcSEcCtD
Carfilzomib—Diarrhoea—Timolol—glaucoma	0.000679	0.0011	CcSEcCtD
Carfilzomib—Dizziness—Timolol—glaucoma	0.000657	0.00106	CcSEcCtD
Carfilzomib—Vomiting—Timolol—glaucoma	0.000631	0.00102	CcSEcCtD
Carfilzomib—Headache—Timolol—glaucoma	0.000622	0.001	CcSEcCtD
Carfilzomib—Nausea—Timolol—glaucoma	0.00059	0.000952	CcSEcCtD
Carfilzomib—PSMB8—Gene Expression—CDKN2B—glaucoma	0.000194	0.000509	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NGFR—glaucoma	0.000193	0.000506	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NGFR—glaucoma	0.000192	0.000504	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GSTM1—glaucoma	0.000191	0.000503	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GSTM1—glaucoma	0.00019	0.0005	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—BAD—glaucoma	0.00019	0.000498	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—BAD—glaucoma	0.000189	0.000496	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1A—glaucoma	0.000188	0.000496	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1A—glaucoma	0.000188	0.000496	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1A—glaucoma	0.000188	0.000496	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—APOE—glaucoma	0.000188	0.000494	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—APOE—glaucoma	0.000187	0.000492	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CAV1—glaucoma	0.000186	0.000489	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SMO—glaucoma	0.000186	0.000489	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SMO—glaucoma	0.000186	0.000489	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SMO—glaucoma	0.000186	0.000489	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1A—glaucoma	0.000186	0.000489	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CAV1—glaucoma	0.000185	0.000487	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SMO—glaucoma	0.000183	0.000482	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NTRK1—glaucoma	0.000183	0.000481	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CDKN2B—glaucoma	0.000182	0.00048	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CDKN2B—glaucoma	0.000182	0.00048	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CDKN2B—glaucoma	0.000182	0.00048	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NTRK1—glaucoma	0.000182	0.000479	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CYP1B1—glaucoma	0.000181	0.000477	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ABCA1—glaucoma	0.000181	0.000477	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CYP1B1—glaucoma	0.000181	0.000477	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ABCA1—glaucoma	0.000181	0.000477	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ABCA1—glaucoma	0.000181	0.000477	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CYP1B1—glaucoma	0.000181	0.000477	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—CDKN1B—glaucoma	0.00018	0.000474	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—CDKN1B—glaucoma	0.00018	0.000474	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—CDKN1B—glaucoma	0.00018	0.000474	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CDKN2B—glaucoma	0.00018	0.000473	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ABCA1—glaucoma	0.000179	0.00047	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CYP1B1—glaucoma	0.000179	0.00047	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—CDKN1B—glaucoma	0.000178	0.000467	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—glaucoma	0.000177	0.000465	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000176	0.000462	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—BAD—glaucoma	0.000175	0.00046	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—BAD—glaucoma	0.000174	0.000458	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—NR3C1—glaucoma	0.000172	0.000453	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—NR3C1—glaucoma	0.000172	0.000453	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—NR3C1—glaucoma	0.000172	0.000453	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NTRK2—glaucoma	0.00017	0.000447	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NTRK2—glaucoma	0.00017	0.000447	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NTRK2—glaucoma	0.00017	0.000447	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—NR3C1—glaucoma	0.00017	0.000447	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—MTHFR—glaucoma	0.000169	0.000444	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CDKN2B—glaucoma	0.000169	0.000443	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—MTHFR—glaucoma	0.000168	0.000442	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CDKN2B—glaucoma	0.000168	0.000441	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NTRK2—glaucoma	0.000168	0.000441	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—C3—glaucoma	0.000166	0.000435	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—C3—glaucoma	0.000166	0.000435	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—C3—glaucoma	0.000166	0.000435	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CDKN1B—glaucoma	0.000165	0.000434	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CDKN1B—glaucoma	0.000165	0.000434	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CDKN1B—glaucoma	0.000165	0.000434	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000164	0.000432	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—C3—glaucoma	0.000163	0.000429	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CDKN1B—glaucoma	0.000163	0.000428	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EDN1—glaucoma	0.000162	0.000425	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EDN1—glaucoma	0.000161	0.000423	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—BCL2L1—glaucoma	0.000159	0.000417	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—BCL2L1—glaucoma	0.000159	0.000417	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—BCL2L1—glaucoma	0.000159	0.000417	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—APOE—glaucoma	0.000157	0.000414	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—APOE—glaucoma	0.000157	0.000412	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—BCL2L1—glaucoma	0.000156	0.000411	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—CAV1—glaucoma	0.000156	0.00041	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—CAV1—glaucoma	0.000155	0.000408	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—MTHFR—glaucoma	0.000153	0.000402	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—MTHFR—glaucoma	0.000153	0.000402	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—MTHFR—glaucoma	0.000153	0.000402	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MTHFR—glaucoma	0.000151	0.000396	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—TP53—glaucoma	0.000149	0.000393	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NGF—glaucoma	0.000149	0.000391	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—TP53—glaucoma	0.000149	0.000391	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NGF—glaucoma	0.000148	0.000389	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NGFR—glaucoma	0.000146	0.000384	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NGFR—glaucoma	0.000146	0.000384	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NGFR—glaucoma	0.000146	0.000384	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GSTM1—glaucoma	0.000145	0.000381	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GSTM1—glaucoma	0.000145	0.000381	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GSTM1—glaucoma	0.000145	0.000381	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NGFR—glaucoma	0.000144	0.000378	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—BAD—glaucoma	0.000144	0.000378	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—BAD—glaucoma	0.000144	0.000378	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—BAD—glaucoma	0.000144	0.000378	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GSTM1—glaucoma	0.000143	0.000376	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—APOE—glaucoma	0.000142	0.000374	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—APOE—glaucoma	0.000142	0.000374	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—APOE—glaucoma	0.000142	0.000374	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—BAD—glaucoma	0.000142	0.000372	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—C3—glaucoma	0.000141	0.000371	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CAV1—glaucoma	0.000141	0.000371	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CAV1—glaucoma	0.000141	0.000371	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CAV1—glaucoma	0.000141	0.000371	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NOS3—glaucoma	0.000141	0.00037	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—C3—glaucoma	0.000141	0.00037	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—APOE—glaucoma	0.00014	0.000369	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NOS3—glaucoma	0.00014	0.000368	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CAV1—glaucoma	0.000139	0.000366	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NTRK1—glaucoma	0.000139	0.000364	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NTRK1—glaucoma	0.000139	0.000364	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NTRK1—glaucoma	0.000139	0.000364	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NTRK1—glaucoma	0.000137	0.000359	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CA1—glaucoma	0.000134	0.000352	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—BAD—glaucoma	0.000133	0.000349	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—BAD—glaucoma	0.000133	0.000349	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—BAD—glaucoma	0.000133	0.000349	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CDKN1B—glaucoma	0.000132	0.000347	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—APOE—glaucoma	0.000132	0.000346	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CDKN1B—glaucoma	0.000131	0.000345	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—APOE—glaucoma	0.000131	0.000344	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—BAD—glaucoma	0.000131	0.000344	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CAV1—glaucoma	0.00013	0.000343	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CTSA—glaucoma	0.00013	0.000341	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CAV1—glaucoma	0.00013	0.000341	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000129	0.00034	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PTGS2—glaucoma	0.000129	0.000338	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTGS2—glaucoma	0.000128	0.000337	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MTHFR—glaucoma	0.000128	0.000337	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MTHFR—glaucoma	0.000128	0.000337	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MTHFR—glaucoma	0.000128	0.000337	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CDKN2B—glaucoma	0.000128	0.000336	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CDKN2B—glaucoma	0.000128	0.000336	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CDKN2B—glaucoma	0.000128	0.000336	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MTHFR—glaucoma	0.000126	0.000332	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CDKN2B—glaucoma	0.000126	0.000331	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FN1—glaucoma	0.000124	0.000326	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FN1—glaucoma	0.000123	0.000325	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EDN1—glaucoma	0.000123	0.000322	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EDN1—glaucoma	0.000123	0.000322	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EDN1—glaucoma	0.000123	0.000322	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—BAD—glaucoma	0.000123	0.000322	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CA2—glaucoma	0.000123	0.000322	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000122	0.000322	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—BAD—glaucoma	0.000122	0.000321	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CDKN1B—glaucoma	0.000122	0.000321	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CDKN1B—glaucoma	0.000121	0.000319	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EDN1—glaucoma	0.000121	0.000318	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—APOE—glaucoma	0.000119	0.000313	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—APOE—glaucoma	0.000119	0.000313	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—APOE—glaucoma	0.000119	0.000313	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CAV1—glaucoma	0.000118	0.000311	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CAV1—glaucoma	0.000118	0.000311	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CAV1—glaucoma	0.000118	0.000311	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—NOS3—glaucoma	0.000118	0.00031	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—APOE—glaucoma	0.000118	0.000309	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—NOS3—glaucoma	0.000117	0.000308	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CAV1—glaucoma	0.000116	0.000306	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—glaucoma	0.000113	0.000298	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—glaucoma	0.000113	0.000298	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—glaucoma	0.000113	0.000298	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NGF—glaucoma	0.000113	0.000296	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NGF—glaucoma	0.000113	0.000296	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NGF—glaucoma	0.000113	0.000296	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—glaucoma	0.000112	0.000293	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NGF—glaucoma	0.000111	0.000292	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—glaucoma	0.000108	0.000283	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—glaucoma	0.000107	0.000282	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—C3—glaucoma	0.000107	0.000282	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—C3—glaucoma	0.000107	0.000282	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—C3—glaucoma	0.000107	0.000282	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS3—glaucoma	0.000107	0.00028	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS3—glaucoma	0.000107	0.00028	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS3—glaucoma	0.000107	0.00028	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—C3—glaucoma	0.000106	0.000278	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS3—glaucoma	0.000105	0.000276	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000102	0.000268	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CDKN1B—glaucoma	0.0001	0.000263	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CDKN1B—glaucoma	0.0001	0.000263	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CDKN1B—glaucoma	0.0001	0.000263	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APOE—glaucoma	9.97e-05	0.000262	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APOE—glaucoma	9.97e-05	0.000262	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APOE—glaucoma	9.97e-05	0.000262	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CAV1—glaucoma	9.88e-05	0.00026	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CAV1—glaucoma	9.88e-05	0.00026	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CAV1—glaucoma	9.88e-05	0.00026	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CDKN1B—glaucoma	9.87e-05	0.000259	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NOS3—glaucoma	9.85e-05	0.000259	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APOE—glaucoma	9.83e-05	0.000258	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NOS3—glaucoma	9.81e-05	0.000258	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—glaucoma	9.75e-05	0.000256	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—glaucoma	9.75e-05	0.000256	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—glaucoma	9.75e-05	0.000256	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CAV1—glaucoma	9.74e-05	0.000256	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—glaucoma	9.62e-05	0.000253	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FN1—glaucoma	9.4e-05	0.000247	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FN1—glaucoma	9.4e-05	0.000247	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FN1—glaucoma	9.4e-05	0.000247	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—BAD—glaucoma	9.29e-05	0.000244	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—BAD—glaucoma	9.29e-05	0.000244	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—BAD—glaucoma	9.29e-05	0.000244	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FN1—glaucoma	9.27e-05	0.000244	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CDKN1B—glaucoma	9.24e-05	0.000243	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CDKN1B—glaucoma	9.24e-05	0.000243	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CDKN1B—glaucoma	9.24e-05	0.000243	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—BAD—glaucoma	9.16e-05	0.000241	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CDKN1B—glaucoma	9.11e-05	0.000239	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NOS3—glaucoma	8.93e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NOS3—glaucoma	8.93e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NOS3—glaucoma	8.93e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NOS3—glaucoma	8.81e-05	0.000232	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	8.72e-05	0.000229	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TXN—glaucoma	8.63e-05	0.000227	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CDKN1B—glaucoma	8.54e-05	0.000224	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CDKN1B—glaucoma	8.5e-05	0.000223	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—glaucoma	8.17e-05	0.000215	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—glaucoma	8.17e-05	0.000215	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—glaucoma	8.17e-05	0.000215	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—glaucoma	8.05e-05	0.000212	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—glaucoma	7.91e-05	0.000208	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—glaucoma	7.87e-05	0.000207	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	7.69e-05	0.000202	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NOS3—glaucoma	7.47e-05	0.000196	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NOS3—glaucoma	7.47e-05	0.000196	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NOS3—glaucoma	7.47e-05	0.000196	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NOS3—glaucoma	7.36e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—VEGFA—glaucoma	7.1e-05	0.000187	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—VEGFA—glaucoma	7.07e-05	0.000186	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTT1—glaucoma	6.69e-05	0.000176	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CDKN1B—glaucoma	6.47e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CDKN1B—glaucoma	6.47e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CDKN1B—glaucoma	6.47e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CDKN1B—glaucoma	6.38e-05	0.000168	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—glaucoma	5.99e-05	0.000158	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—glaucoma	5.99e-05	0.000158	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—glaucoma	5.99e-05	0.000158	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—glaucoma	5.91e-05	0.000155	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VEGFA—glaucoma	5.38e-05	0.000141	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VEGFA—glaucoma	5.38e-05	0.000141	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VEGFA—glaucoma	5.38e-05	0.000141	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—glaucoma	5.36e-05	0.000141	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—glaucoma	5.34e-05	0.00014	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP1B1—glaucoma	5.33e-05	0.00014	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ABCA1—glaucoma	5.33e-05	0.00014	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VEGFA—glaucoma	5.3e-05	0.000139	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTM1—glaucoma	4.26e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—glaucoma	4.07e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—glaucoma	4.07e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—glaucoma	4.07e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—glaucoma	4.01e-05	0.000105	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MTHFR—glaucoma	3.77e-05	9.91e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOE—glaucoma	3.51e-05	9.22e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CAV1—glaucoma	3.48e-05	9.14e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NOS3—glaucoma	2.63e-05	6.91e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—glaucoma	2.4e-05	6.32e-05	CbGpPWpGaD
